CyCLE: CyPass Clinical Experience Study
Sponsor
Transcend Medical, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT01097174
Collaborator
(none)
555
14
67
39.6
0.6
Study Details
Study Description
Brief Summary
This study is to evaluate the long-term safety, effectiveness and clinical experience of the CyPass Micro-Stent in patients with glaucoma.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
555 participants
Observational Model:
Case-Only
Time Perspective:
Other
Official Title:
A Multicenter Registry Study to Capture Data With Respect to CyPass Clinical Experience
Study Start Date
:
Dec 1, 2009
Actual Primary Completion Date
:
Jul 1, 2015
Actual Study Completion Date
:
Jul 1, 2015
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
CyPass Micro-stent Patients in whom CyPass Micro-stent implantation was attempted. |
Device: CyPass Micro-Stent
The CyPass Micro-Stent is a small tube with a through-lumen designed to redirect aqueous fluid from the front into the back of they eye.
|
Outcome Measures
Primary Outcome Measures
- Incidence of intraoperative and postoperative adverse events [Day 0 - Year 3]
Secondary Outcome Measures
- Intraocular pressure (IOP) reduction [1 - 36 months postoperatively]
- Ocular hypotensive medication use [1 - 36 months postoperatively]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Diagnosis of OAG
-
IOP ≥ 21 mmHg and ≤ 31 mmHg (with or without ocular hypotensive medication)
Exclusion Criteria:
-
Acute angle closure, narrow angle, uveitic or neovascular glaucoma
-
Normal tension glaucoma
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Eye Clinic | Salzburg | Austria | ||
2 | Specialized Hospital for Active Treatment of Ophthalmologic Diseases | Sofia | Bulgaria | ||
3 | Schlosspark-Klinik, Department of Ophthalmology | Berlin | Germany | ||
4 | Knappschaftskrankenhaus Bochum-Langendreer | Bochum | Germany | ||
5 | AugenKlinik Cham | Cham | Germany | ||
6 | Klinik fur Augenheilkunde, Campus Lubeck | Lubeck | Germany | ||
7 | Klinik für Augenheilkunde, Dietrich-Bonhoeffer-Klinikum | Neubrandenburg | Germany | ||
8 | Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazio | Catania | Italy | ||
9 | Wojskowy Instytut Medyczny (Military Medical Institute) | Warsaw | Poland | ||
10 | Institut Catala de Retina | Barcelona | Spain | ||
11 | Instituto de Microcirugia Ocular | Barcelona | Spain | ||
12 | Hospital Clinico San Carlos | Madrid | Spain | ||
13 | Ramón y Cajal University Hospital | Madrid | Spain | ||
14 | Hospital Universiatrio Miguel Servet | Zaragoza | Spain |
Sponsors and Collaborators
- Transcend Medical, Inc.
Investigators
- Study Director: Tsontcho (Sean) Ianchulev, MD, MPH, Transcend Medical, Inc.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Transcend Medical, Inc.
ClinicalTrials.gov Identifier:
NCT01097174
Other Study ID Numbers:
- TMI-09-02
First Posted:
Apr 1, 2010
Last Update Posted:
May 15, 2017
Last Verified:
Oct 1, 2016
Keywords provided by Transcend Medical, Inc.
Additional relevant MeSH terms: